Cardiol Therapeutics Class Stock Buy Hold or Sell Recommendation
| CRDL Stock | CAD 2.31 0.11 5.00% |
Assuming the 90 days trading horizon and your complete indifference towards market risk, our recommendation regarding Cardiol Therapeutics Class is 'Strong Buy'. The recommendation algorithm takes into account all of Cardiol Therapeutics' available fundamental, technical, and predictive indicators you will find on this site.
Check out Cardiol Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Cardiol and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Cardiol Therapeutics Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Cardiol |
Execute Cardiol Therapeutics Buy or Sell Advice
The Cardiol recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cardiol Therapeutics Class. Macroaxis does not own or have any residual interests in Cardiol Therapeutics Class or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cardiol Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Responds to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Cardiol Therapeutics Trading Alerts and Improvement Suggestions
| Cardiol Therapeutics generated a negative expected return over the last 90 days | |
| Cardiol Therapeutics has high historical volatility and very poor performance | |
| Cardiol Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (28.13 M) with profit before overhead, payroll, taxes, and interest of 78.76 K. | |
| Cardiol Therapeutics Class has accumulated about 59.47 M in cash with (25.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48. | |
| Latest headline from news.google.com: Cardiol Therapeutics Shares Up 1.8 percent - Whats Next - MarketBeat |
Cardiol Therapeutics Returns Distribution Density
The distribution of Cardiol Therapeutics' historical returns is an attempt to chart the uncertainty of Cardiol Therapeutics' future price movements. The chart of the probability distribution of Cardiol Therapeutics daily returns describes the distribution of returns around its average expected value. We use Cardiol Therapeutics Class price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cardiol Therapeutics returns is essential to provide solid investment advice for Cardiol Therapeutics.
| Mean Return | -0.11 | Value At Risk | -5.77 | Potential Upside | 6.67 | Standard Deviation | 3.83 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cardiol Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Cardiol Therapeutics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 142.6K | 1.1M | 18.0K | (4.5M) | (5.1M) | (4.9M) | |
| Investments | (424.3K) | (40.6K) | (12.9K) | (74.7K) | (101.4K) | (106.5K) | |
| Change In Cash | (9.8M) | 7.1M | 69.9M | (24.4M) | (24.5M) | (23.3M) | |
| Net Borrowings | (20.2K) | (50.5K) | (51.9K) | (53.9K) | (48.5K) | (46.1K) | |
| Free Cash Flow | (11.8M) | (9.2M) | (23.6M) | (27.3M) | (25.2M) | (24.0M) | |
| Depreciation | 150.6K | 229.5K | 220.4K | 219.9K | 248.4K | 190.7K | |
| Other Non Cash Items | 507.7K | 145.0K | 4.2M | (7.3M) | 4.8M | 5.1M | |
| Capital Expenditures | 424.3K | 40.6K | 12.9K | 74.7K | 64.3K | 75.4K | |
| Net Income | (13.7M) | (20.6M) | (31.6M) | (30.9M) | (28.1M) | (29.5M) | |
| End Period Cash Flow | 7.0M | 14.0M | 83.9M | 59.5M | 34.9M | 34.3M | |
| Change To Netincome | 3.8M | 2.9M | 7.8M | (2.3M) | (2.0M) | (1.9M) |
Cardiol Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cardiol Therapeutics or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cardiol Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cardiol stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.26 | |
β | Beta against Dow Jones | 1.27 | |
σ | Overall volatility | 3.95 | |
Ir | Information ratio | -0.06 |
Cardiol Therapeutics Volatility Alert
Cardiol Therapeutics Class exhibits very low volatility with skewness of 0.4 and kurtosis of 0.84. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cardiol Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cardiol Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Cardiol Therapeutics Fundamentals Vs Peers
Comparing Cardiol Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cardiol Therapeutics' direct or indirect competition across all of the common fundamentals between Cardiol Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cardiol Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cardiol Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Cardiol Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Cardiol Therapeutics to competition |
| Fundamentals | Cardiol Therapeutics | Peer Average |
| Return On Equity | -1.08 | -0.31 |
| Return On Asset | -0.54 | -0.14 |
| Current Valuation | 172.78 M | 16.62 B |
| Shares Outstanding | 81.6 M | 571.82 M |
| Shares Owned By Insiders | 3.91 % | 10.09 % |
| Shares Owned By Institutions | 9.50 % | 39.21 % |
| Number Of Shares Shorted | 263.21 K | 4.71 M |
| Price To Book | 18.07 X | 9.51 X |
| Price To Sales | 1,274 X | 11.42 X |
| Gross Profit | 78.76 K | 27.38 B |
| EBITDA | (29.54 M) | 3.9 B |
| Net Income | (28.13 M) | 570.98 M |
| Cash And Equivalents | 59.47 M | 2.7 B |
| Cash Per Share | 0.48 X | 5.01 X |
| Total Debt | 174.34 K | 5.32 B |
| Debt To Equity | 1.00 % | 48.70 % |
| Current Ratio | 24.67 X | 2.16 X |
| Book Value Per Share | 0.43 X | 1.93 K |
| Cash Flow From Operations | (25.18 M) | 971.22 M |
| Short Ratio | 2.22 X | 4.00 X |
| Earnings Per Share | (0.54) X | 3.12 X |
| Target Price | 11.0 | |
| Beta | 0.7 | -0.15 |
| Market Capitalization | 188.5 M | 19.03 B |
| Total Asset | 36.7 M | 29.47 B |
| Retained Earnings | (142.58 M) | 9.33 B |
| Working Capital | 51.63 M | 1.48 B |
| Net Asset | 36.7 M |
Cardiol Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cardiol . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 5248.95 | |||
| Daily Balance Of Power | 0.5 | |||
| Rate Of Daily Change | 1.05 | |||
| Day Median Price | 2.2 | |||
| Day Typical Price | 2.24 | |||
| Price Action Indicator | 0.17 | |||
| Period Momentum Indicator | 0.11 |
About Cardiol Therapeutics Buy or Sell Advice
When is the right time to buy or sell Cardiol Therapeutics Class? Buying financial instruments such as Cardiol Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cardiol Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Agriculture Thematic Idea Now
Agriculture
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Agriculture theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Agriculture Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Cardiol Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.